Funds and ETFs Ono Pharmaceutical Co., Ltd.

4528

JP3197600004

Name	Weight	AuM	1st Jan change	Investor Rating
NOMURA NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF - JPY	3.23%	15 M€	+7.34%
NEXT FUNDS SOLACTIVE JAPAN ESG CORE INDEX ETF - JPY	0.67%	251 M€	+13.17%
RBC QUANT EAFE EQUITY LEADERS ETF - USD	0.49%	2 M€	+9.19%	-
RBC QUANT EAFE EQUITY LEADERS (CAD HEDGED) ETF - HEDGED CAD	0.49%	2 M€	-.--%	-
GLOBAL X MSCI GOVERNANCE-QUALITY JAPAN ETF - JPY	0.46%	11 M€	+10.37%	-
NOMURA NEXT FUNDS NOMURA ENTERPRISE VALUE ALLOCATION INDEX ETF - JPY	0.40%	73 M€	+11.61%
DAIWA ETF MSCI JAPAN EMPOWERING WOMEN INDEX ETF - JPY	0.37%	4 M€	+13.95%
DAIWA ETF MSCI JAPAN ESG SELECT LEADERS INDEX ETF - JPY	0.33%	81 M€	+14.05%
NZAM ETF TOPIX EX-FINANCIALS - JPY	0.30%	18 M€	+16.15%	-
DAIWA ETF FTSE BLOSSOM JAPAN INDEX ETF - JPY	0.29%	14 M€	+15.63%
NOMURA NEXT FUNDS JPX-NIKKEI INDEX 400 ETF - JPY	0.25%	10,207 M€	+14.32%
MAXIS JPX-NIKKEI 400 ETF - JPY	0.25%	5,115 M€	+13.58%
ISHARES EDGE MSCI MULTIFACTOR EAFE INDEX ETF (CAD-HEDGED) - CAD	0.24%	5 M€	+10.09%	-
ISHARES EDGE MSCI MULTIFACTOR EAFE INDEX ETF - CAD	0.24%	14 M€	+5.66%	-
NOMURA TOPIX EXCHANGE TRADED FUND ETF - JPY	0.18%	144,586 M€	+14.49%
DAIWA ETF TOPIX ETF - JPY	0.18%	66,066 M€	+14.68%	-
MAXIS TOPIX ETF - JPY	0.18%	20,721 M€	+13.52%	-
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD	0.14%	1,120 M€	+0.40%
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	0.14%	469 M€	-2.05%	-
AMUNDI INDEX MSCI WORLD SRI PAB UCITS ETF - EUR	0.14%	3,859 M€	+18.82%	-
ISHARES ESG MSCI EAFE LEADERS INDEX ETF - CAD	0.09%	4 M€	-.--%	-
DEMOCRACY INTERNATIONAL FUND ETF - USD	0.05%	7 M€	+1.95%	-
IMGP RBA RESPONSIBLE GLOBAL ALLOCATION ETF - USD	0.05%	7 M€	+0.11%	-
LEVERAGE SHARES 3X LONG TOTAL WORLD ETP SECURITIES - USD	0.04%	0 M€	0.00%	-

ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in the clinical development, introduction and derivation of pharmaceuticals.

Sector

Pharmaceuticals

Calendar

2024-05-08 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Ono Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,300 JPY

Average target price

2,656 JPY

Spread / Average Target

+15.47%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19.62%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+10.86%	14.09B
CIPLA LIMITED	+13.07%	13.64B
ZYDUS LIFESCIENCES LIMITED	+37.46%	11.43B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-4.29%	4.71B

Generic Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
2,300 ^JPY	+1.34%		+2.77%	-8.59%

Mar. 21	ONO Pharmaceuticals, Co., Ltd. Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL	CI
Mar. 14	Sibylla Biotech Enters Strategic Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd. in Central Nervous System Disorders	CI